BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22227000)

  • 1. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
    Castiglioni V; Onorati M; Rochon C; Cattaneo E
    Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.
    Camnasio S; Delli Carri A; Lombardo A; Grad I; Mariotti C; Castucci A; Rozell B; Lo Riso P; Castiglioni V; Zuccato C; Rochon C; Takashima Y; Diaferia G; Biunno I; Gellera C; Jaconi M; Smith A; Hovatta O; Naldini L; Di Donato S; Feki A; Cattaneo E
    Neurobiol Dis; 2012 Apr; 46(1):41-51. PubMed ID: 22405424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
    Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
    Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of Huntington's disease-affected human embryonic stem cell lines.
    Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
    Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
    Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
    Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice.
    Chu-LaGraff Q; Kang X; Messer A
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):307-12. PubMed ID: 11719265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.
    Sathasivam K; Woodman B; Mahal A; Bertaux F; Wanker EE; Shima DT; Bates GP
    Hum Mol Genet; 2001 Oct; 10(21):2425-35. PubMed ID: 11689489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
    Lorincz MT; Zawistowski VA
    Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
    Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
    Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice.
    Ransome MI; Hannan AJ
    Mol Cell Neurosci; 2013 May; 54():93-107. PubMed ID: 23384443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
    McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress causes DNA triplet expansion in Huntington's disease mouse embryonic stem cells.
    Jonson I; Ougland R; Klungland A; Larsen E
    Stem Cell Res; 2013 Nov; 11(3):1264-71. PubMed ID: 24041806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.
    Szlachcic WJ; Switonski PM; Krzyzosiak WJ; Figlerowicz M; Figiel M
    Dis Model Mech; 2015 Sep; 8(9):1047-57. PubMed ID: 26092128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming Huntington monkey skin cells into pluripotent stem cells.
    Chan AW; Cheng PH; Neumann A; Yang JJ
    Cell Reprogram; 2010 Oct; 12(5):509-17. PubMed ID: 20936902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
    Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
    Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease.
    Kohl Z; Kandasamy M; Winner B; Aigner R; Gross C; Couillard-Despres S; Bogdahn U; Aigner L; Winkler J
    Brain Res; 2007 Jun; 1155():24-33. PubMed ID: 17512917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset.
    Vatsavayai SC; Dallérac GM; Milnerwood AJ; Cummings DM; Rezaie P; Murphy KP; Hirst MC
    Brain Res Bull; 2007 Apr; 72(2-3):98-102. PubMed ID: 17352932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.